Melanoma Peptide MHC Specific TCR Expressing T-Cell Membrane Camouflaged PLGA Nanoparticles for Treatment of Melanoma Skin Cancer

Melanoma is one of the most aggressive skin cancers, and the American Cancer Society reports that every hour, one person dies from melanoma. While there are a number of treatments currently available for melanoma (e.g., surgery, chemotherapy, immunotherapy, and radiation therapy), they face several...

Descripción completa

Detalles Bibliográficos
Autores principales: Yaman, Serkan, Ramachandramoorthy, Harish, Oter, Gizem, Zhukova, Daria, Nguyen, Tam, Sabnani, Manoj K., Weidanz, Jon A., Nguyen, Kytai T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431670/
https://www.ncbi.nlm.nih.gov/pubmed/32850765
http://dx.doi.org/10.3389/fbioe.2020.00943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431670/
https://www.ncbi.nlm.nih.gov/pubmed/32850765
http://dx.doi.org/10.3389/fbioe.2020.00943

Ejemplares similares